A specialty pharmaceutical manufacturer focused on branded and generic drugs across gastroenterology, dermatology, neurology, and eye health. The company operates globally and generates revenue from a portfolio of legacy products and prescription therapies, while continuing to manage a large debt lo...
3 members of Congress have disclosed 11 trades in Bausch Health Companies Inc. (BHC), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| 2020-01-06 | Susie Lee | buy | $1K – $15K |
| 2018-08-21 | JAMES B. RENACCI | sell | $1K – $15K |
| 2016-05-16 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-04-22 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-04-12 | JAMES B. RENACCI | sell | $15K – $50K |
| 2016-04-12 | JAMES B. RENACCI | sell | $50K – $100K |
| 2016-02-19 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-10-07 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2015-10-06 | MICHAEL T. MCCAUL | sell | $1K – $15K |